Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma

Cancer

Volumn 88, Issue 10, 2000, Pages 2372-2377

  Hattori, Hiroyoshi ^a   Matsuzaki, Akinobu ^a   Suminoe, Aiko ^a   Ihara, Kenji ^a   Eguchi, Mariko ^b   Tajiri, Tatsurou ^a   Suita, Sachiyo ^a   Ishii, Eiichi ^c   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HAMANOMACHI HOSPITAL   (Japan)

Author keywords

Genomic imprinting; Infant leukemia; Insulin like growth factor 2; Loss of imprinting; Neuroblastoma

Indexed keywords

COMPLEMENTARY DNA; RNA; SOMATOMEDIN B;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; GENOME; GENOTYPE; HUMAN; INFANT; LEUKEMIA; MALE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

FEMALE; GENOMIC IMPRINTING; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR II; LEUKEMIA; MALE; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0034656993     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000515)88:10<2372::AID-CNCR23>3.0.CO;2-A     Document Type: Article

References (36)

1. Mutter GL. Role of imprinting in abnormal human development. Mutat Res 1997;396:141-7.
2. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Pathol 1999;154:635-47.
3. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet 1993;4:98-101.
4. Morison IM, Reeve AE. Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. Mol Med Today 1998;4:110-5.
5. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-51.
6. Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 1994;94:445-8.
7. Yun K. Genomic imprinting and carcinogenesis. Histol Histopathol 1998;13:425-35.
8. Randhawa GS, Cui H, Barletta JA, Strichman-Almashanu LZ, Talpaz M, Kantarjian H, et al. Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood 1998; 91:3144-7.
9. Wu HK, Weksberg R, Minden MD, Squire JA. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia. Biochem Biophys Res Commun 1997;231:466-72.
10. Wada M, Seeger RC, Mizoguchi H, Koeffler HP. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Cancer Res 1995;55:3386-8.
11. Rainier S, Dobry CJ, Feinberg AP. Loss of imprinting in hepatoblastoma. Cancer Res 1995;55:1836-8.
12. Davies SM. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res 1993;53:4781-3.
13. Suminoe A, Matsuzaki A, Kinukawa N, Inamitsu T, Tajiri T, Suita S, et al. Rapid somatic growth after birth in children with neuroblastoma: a survey of 1718 patients with childhood cancer in Kyushu-Okinawa district. J Pediatr 1999;134:178-84.
14. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988;6:1874-81.
15. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
16. Shimada H, Chatten J, Newton WA Jr., Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
17. Lighten AD, Hardy K, Winston RM, Moore GE. IGF2 is parentally imprinted in human preimplantation embryos. Nat Genet 1997;15:122-3.
18. Wu HK, Squire JA, Song Q, Weksberg R. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues. Biochem Biophys Res Commun 1997;233:221-6.
19. Giannoukakis N, Deal C, Paquette J, Kukuvitis A, Polychronakos C. Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem Biophys Res Commun 1996;220:1014-9.
20. Davies SM. Developmental regulation of genomic imprinting of the IGF2 gene in human liver. Cancer Res 1994;54:2560-2.
21. Oda H, Kume H, Shimizu Y, Inoue T, Ishikawa T. Loss of imprinting of IGF2 in renal-cell carcinomas. Int J Cancer 1998;75:343-6.
22. Nonomura N, Nishimura K, Miki T, Kanno N, Kojima Y, Yokoyama M, et al. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma. Cancer Res 1997;57:2575-7.
23. Kim HT, Choi BH, Niikawa N, Lee TS, Chang SI. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am J Med Genet 1998;80:391-5.
24. Yun K, Fukumoto M, Jinno Y. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer. Am J Pathol 1996;148:1081-7.
25. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993;362:747-9.
26. Ross JA, Schmidt PT, Perentesis JP, Davies SM. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors. Cancer 1999;85:1389-94.
27. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A 1997;94:13950-4.
28. Rowley JD. Backtracking leukemia to birth. Nat Med 1998;4: 150-1.
29. Kim KS, Lee YI. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 1997;119:143-8.
30. Uchida K, Kondo M, Takeda S, Osada H, Takahashi T, Nakao A. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinog 1997;18:193-8.
31. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC, Pahlman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 1995;146:833-47.
32. O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, et al. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 1997;21:822-5.
33. Vafiadis P, Bennett ST, Todd JA, Grabs R, Polychronakos C. Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. J Clin Endocrinol Metab 1998;83:2933-9.
34. Kato MV, Ishizaki K, Shimizu T, Ejima Y, Tanooka H, Takayama J, et al. Parental origin of germ-line and somatic mutations in the retinoblastoma gene. Hum Genet 1994;94:31-8.
35. Munier FL, Thonney F, Balmer A, Heon E, Pescia G, Schorderet DF. Sex mutation ratio in retinoblastoma and retinoma: relevance to genetic counseling. Klin Monatsbl Augenheilkd 1996;208:400-3.
36. Ross JA, Perentesis JP, Robison LL, Davies SM. Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control 1996;7:553-9.